WHO adds 4 TB drugs by Macleods to approved list
GENEVA (Reuters) - The World Health Organization (WHO) said on Friday that it had added four anti-tuberculosis drugs made by Indian generics producer Macleods to its list of approved medicines.
The United Nations named the medicines as ethambutol, pyrazinamide, a fixed-dose combination of ethambutol and isoniazid and cycloserine, a second-line drug used when the disease is resistant to standard treatments.
The WHO's so-called 'prequalified list' is designed to make it easier for developing countries to choose which medicines to buy.
© Thomson Reuters 2009 All rights reserved
Finding the profit prescription
Pharmaceutical companies are striking mega deals, diversifying and cutting costs but Wall Street skepticism persists in many corners of the healthcare industry. Full Coverage
Obama vows "justice" for shooter